NIH-funded research R21 grant

Identifying leaky gut in premature infants using stool samples

Official title: Mucosal immune biomarkers to detect neonatal leaky gut

Funded at University of Maryland Baltimore · NIH-10816562 · Data updated 2026-11-12

This study is looking at how to spot 'leaky gut' in premature babies by checking their stool samples for certain markers, which could help doctors find out who might be at risk for a serious condition called necrotizing enterocolitis (NEC) before any symptoms show up, making it easier to keep these little ones healthy.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$193,125
NIH project number5R21HD111907-02
Project IDNIH-10816562 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are premature infants born before 33 weeks of gestation.

Less likely to help

Patients who are full-term infants or those who do not exhibit signs of leaky gut may not benefit from this research.

What this research studies

This research investigates how to detect 'leaky gut' in premature infants, a condition that can lead to a serious gastrointestinal emergency called necrotizing enterocolitis (NEC). By analyzing immune biomarkers found in stool samples, the study aims to identify infants at risk for NEC before symptoms develop. The approach involves using existing samples from a cohort of preterm infants, examining their gut microbiome and intestinal permeability. This non-invasive method could help healthcare providers monitor and manage the health of vulnerable newborns more effectively.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection of at-risk infants, potentially reducing the severity and mortality associated with necrotizing enterocolitis.

How similar studies have gone: Similar research approaches have shown promise in identifying biomarkers for various conditions, suggesting potential success for this novel method.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Ma, Bing — University of Maryland Baltimore
  • Study coordinator: Ma, Bing

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.